Exploration the Standard diagnosis and treatment in Patients with Type 2 Diabetes in a tertiary first-class hospital in Fujian Province

Author:

Lin Xiaoyan,Lin Wei,Wen Junping,Chen GangORCID

Abstract

ObjectiveThe aim of this study was to evaluate the knowledge and clinical practice of ‘‘guideline for prevention and treatment of Type 2 diabetes in China’’ among the physicians. We took a tertiary first-class hospital in Fujian Province as an example to identify the differences between clinical practice and guideline.MethodsWe selected 3000 inpatients with type 2 diabetes who visited at the tertiary first-class hospital in Fujian Province between September 2017 to November 2017, then retrospectively analyzed their clinical data, including age, gender, height, weight, body mess index, admission departments, combined diseases, complications, course of disease, diabetes diet education, monitoring of blood glucose and blood pressure, the selection of hypoglycemic therapy and other secondary prevention measures. The data we obtained was analyzed by SPSS 19.0 software.ResultsA total of 3000 effective inpatient were enrolled, including 1724 male and 1276 female, the mean age(± standard deviation) of patients was 66.21 ± 11.75 years, the mean hospitalization days was 12.26±10.30 days.In this study, we found that:1.only 60.9% of the patients have monitored HbA1C in nearly 3 months; in the last year, 96.3% of patients have monitored blood lipid;98.1% of patients have monitored the serum creatinine;only 9.5% of patients have received comprehensive eye examination by an ophthalmologist or optometrist.2.After admission, 73.3% of patients have received the education about diabetes diet; 86.8% of patients have accepted the peripheral blood glucose monitoring;among 2084 diabetic patients combined with hypertension, only 1868 patients (89.6%) have received blood pressure monitoring.3. Among 202 patients who are newly diagnosed diabetes, there were 45 cases meet HbA1C > 9.0% or FPG > 11.1 mmol/ L, only 25 people (55.56%) have received an intensive insulin therapy.4.Among 474 patients who have undergone an large or medium-sized surgical treatment, about 182(62.1%) patients have started a hypoglycemic therapy before the operation, and only 196(41.4%) patients have changed into intensive insulin therapy before surgery.5. About 714 of diabetic patients who combined with a clear history of cardiovascular, only 548 (76.8%) patients have received antiplatelet therapy;and 566 people (79.3%) have used statin to lower blood lipid. 6.In total, only 168(5.6%) patients have received a relatively standard diagnosis and treatment in non-surgical department, and only 4(0.1%) patients in surgical department.ConclusionThere are still many deficiencies in clinical practice of type 2 diabetes guideline, even in tertiary first-class hospital, there are also many physicians, especially non-specialist doctors, were not familiar with the knowledge of guideline for management of Type 2 diabetes.The acute exacerbation of diabetes in the global can take serious complications and bring heavy economic burden, so it required us to pay attention to the prevention and early treatment of diabetes. We suggest to popularize the “guideline for management of Type 2 diabetes” through various forms, such as academic seminars, lecture tour and medical staffs, so as to enhance the education of physicians and promote treatment based on guideline of type 2 diabetes.

Publisher

Cold Spring Harbor Laboratory

Reference32 articles.

1. Global Prevalence of Diabetes

2. Prevalence of Diabetes among Men and Women in China

3. 陈瀚 珠 , 陈果 为 , 王吉 耀 等. 实用内科学. 第14版. 北京市:人民卫生出版社, 2015, 976–977.

4. 张震 巍. 我国糖尿病疾病负担研究. 上海: 复旦大学, 2007.

5. 全球糖尿病疾病负担现状;中国糖尿病杂志,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3